Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Post-Heart Attack Patients Suffer from Arrhythmias

By HospiMedica International staff writers
Posted on 17 Nov 2010
A new study has detected arrhythmias in 46% of patients who had previously suffered an acute myocardial infarction (AMI), using an insertable cardiac monitor (ICM).

Researchers at Gentofte University Hospital (Copenhagen, Denmark), St Antonious Hospital (Nieuwegein, The Netherlands), and other institutions conducted a multicenter, prospective study to investigate the incidence and prognostic significance of arrhythmias following an AMI. More...
The study population comprised 1,393 of 5,869 patients (24%) screened in the acute phase of an AMI who had left ventricular ejection fraction less than or equal to 40%. After exclusions, 297 patients (21%) with a mean age of 64 years and a mean left ventricular ejection fraction of 31% received an ICM and were followed up every 3 months for an average of almost two years. The end points used in the analysis were cardiac death and all-cause mortality.

The results showed that clinically significant bradyarrhythmias and tachyarrhythmias were documented in a substantial proportion of patients; of those diagnosed with arrhythmias, 27% experienced new onset atrial fibrillation (AF), 9.8% had high-degree atrioventricular (AV) block, 6.7% had sinus bradycardia, and 13% had nonsustained ventricular tachycardia. Additionally, 56 patients received an implantable cardioverter-defibrillator (ICD), and 15 patients received a pacemaker. Cox regression analysis revealed that high-degree AV block was the most powerful predictor of cardiac death. The study was published in the September 28, 2010, issue of Circulation.

"For the first time there are data showing that continuous long-term monitoring allows detailed insight into post-AMI arrhythmias,” said lead author Poul Erik Bloch Thomsen, M.D. "Additional information about post-AMI patients can help physicians determine appropriate medical intervention, such as an implantable cardioverter-defibrillator, pacemaker, or modified drug therapy.”

Related Links:

Gentofte University Hospital
St Antonious Hospital





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.